Oragenics Inc (OGEN)

09:47 AM

Oragenics (OGEN) Gains Approval for Phase II Trial of Neuroprote - GuruFocus

09:47 AM

09:16 AM

Oragenics gains Australia’s nod for concussion therapy trial - Investing.com Australia

09:16 AM

09:03 AM

Oragenics gains Australia’s nod for concussion therapy trial By Investing.com - Investing.com Nigeria

09:03 AM

08:58 AM

Oragenics, Inc. Announces Approval to Initiate Phase II Concussi - GuruFocus

08:58 AM

08:53 AM

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia - The Manila Times

08:53 AM

12:19 PM

Oragenics, Inc. to Host Management Update Webinar on May - GlobeNewswire

12:19 PM

May 12, 2025

Oragenics, Inc. to Host Management Update Webinar on May 20, 202 - GuruFocus

May 12, 2025

May 12, 2025

Oragenics, Inc. to Host Webinar on ONP-002 and Addressing Unmet Needs in Concussion Treatment - Nasdaq

May 12, 2025

May 10, 2025

Oragenics: Q1 Earnings Snapshot - New Haven Register

May 10, 2025

May 07, 2025

Oragenics (NYSE:OGEN) Now Covered by StockNews.com - Defense World

May 07, 2025

May 02, 2025

Oragenics Appoints New CEO and Amends Employment Terms By Investing.com - Investing.com Nigeria

May 02, 2025

May 02, 2025

Oragenics Appoints New CEO and Amends Employment Terms - Investing.com Australia

May 02, 2025

May 02, 2025

Oragenics Appoints Janet Huffman as CEO and CFO - TipRanks

May 02, 2025

Apr 29, 2025

StockNews.com Initiates Coverage on Oragenics (NYSE:OGEN) - Defense World

Apr 29, 2025

Apr 23, 2025

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brai - GuruFocus

Apr 23, 2025

Apr 23, 2025

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference | OGEN Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

Oragenics, Inc. to Present at the 15th Annual Traumatic Brain Injury Conference on Advances in mTBI Detection and Management - Nasdaq

Apr 23, 2025

Apr 23, 2025

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference - GlobeNewswire

Apr 23, 2025

Apr 21, 2025

Oragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.com - Defense World

Apr 21, 2025

Apr 10, 2025

Oragenics, Inc. Announces Health and Disability Ethics Committee - GuruFocus

Apr 10, 2025

Apr 09, 2025

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial - The Manila Times

Apr 09, 2025

Apr 09, 2025

Oragenics Announces Health And Disability Ethics Committee Submission - MarketScreener

Apr 09, 2025

Apr 08, 2025

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit - GlobeNewswire

Apr 08, 2025

Apr 05, 2025

Oragenics gears up for Phase II trials, appoints new CEO - MSN

Apr 05, 2025

Apr 05, 2025

Oragenics (NYSE:OGEN) Coverage Initiated at StockNews.com - Defense World

Apr 05, 2025

Apr 04, 2025

OGEN stock touches 52-week low at $0.19 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

OGEN stock touches 52-week low at $0.19 amid sharp annual decline - Investing.com

Apr 04, 2025

Mar 28, 2025

OGEN stock touches 52-week low at $0.24 amid sharp annual decline - Investing.com Australia

Mar 28, 2025

Mar 27, 2025

Oragenics reports progress in concussion drug development By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

OGEN stock touches 52-week low at $0.24 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Oragenics reports progress in concussion drug development - Investing.com

Mar 27, 2025

Mar 27, 2025

Oragenics Provides Q1 2025 Shareholder Update On Strategic And Financial Progress - MarketScreener

Mar 27, 2025

Mar 27, 2025

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress - The Manila Times

Mar 27, 2025

Mar 20, 2025

Oragenics (NYSE:OGEN) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 20, 2025

Mar 19, 2025

Investornewsbreaks Oragenics Inc. Files 2024 Annual Report, Addresses Going Concern Status - MENAFN.COM

Mar 19, 2025